Navigation Links
From genomic data to new cancer drug
Date:10/27/2011

When the researchers injected EPHA7 into mice with human tumors, those tumors shrunk. They found that a particularly effective way to deliver EPHA7 to cancer cells is to fuse it with an antibody that specifically targets lymphomas.

The researchers say EPHA7 has immediate therapeutic potential, although they intend to pursue smaller versions of the protein that might be easier to make. There is also reason to think EPHA7 may ultimately have promise for the treatment of other forms of cancer as it binds a protein with links to breast and ovarian cancer.


'/>"/>
Contact: Elisabeth (Lisa) Lyons
elyons@cell.com
617-386-2121
Cell Press
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Dana-Farber, Brigham and Womens launch large-scale genomic database project
2. Structural Genomics Project creates blueprint for infectious disease and biodefense research
3. Lung tumors in never-smokers show greater genomic instability than those in smokers
4. Novel analysis method organizes genomic cancer data
5. Genomic test shows promise as chemotherapy response, survival predictor for women with breast cancer
6. Genomic signature in post-menopausal women may explain why pregnancy reduces breast cancer risk
7. New genomics research investigates metastatic childhood cancers
8. Promise of genomics research needs a realistic view
9. NHGRI charts course for the next phase of genomics research
10. Tufts University calls for moderate approach to teaching personalized genomic testing
11. Genomic markers may head off thousands of thyroid surgeries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 ... may be showing a genetic propensity for obesity as toddlers, ... been linked to increased body fat, but the same genes ... the researchers said. At 1 year, kids with these ... 3, however, these genes were linked to excessive weight gain, ...
(Date:10/22/2014)... Oct. 21, 2014 (HealthDay News) -- Measures taken by ... in Ebola-ravaged Liberia may have limited the spread of ... report. The Firestone Natural Rubber Co. provides health ... residents of nearby densely populated communities. Between Aug. ... suspected Ebola cases among those 80,000 people. That incidence ...
(Date:10/20/2014)... Allegheny General Hospital’s (AGH) Cardiovascular Institute is offering ... a damaged mitral valve as the heart continues to ... Abbott Vascular , is designed to treat degenerative ... which the heart’s mitral valve leaflets fail to close ... left ventricle into the left atrium. The heart must ...
(Date:10/20/2014)... 20, 2014 hc1.com today announced ... cloud solution that enables healthcare organizations of all ... healthcare-specific customer relationship management (“CRM”) solution. , Designed ... needs of the healthcare industry, the hc1 Healthcare ... and patients by combining healthcare CRM, HIPAA-compliant collaboration, ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 AttorneyOne.com, a recognized ... latest information from the FDA on Sit and Slim ... 10 not to purchase or use Sit and Slim II ... Slim II is promoted as weight loss product on various ... from the market in 2010 for safety reasons, can significantly ...
Breaking Medicine News(10 mins):Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 3Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2
... , WASHINGTON, Oct. 13 Dr. Charmaine Yoest, President ... statement Tuesday regarding the Finance Committee vote on health care ... the four other committees with jurisdiction over health care reform ... language excluding abortion funding and coverage. In fact, the ...
... Speaker Nancy Pelosi issued the following statement today after ... insurance reform proposal. , "The Senate Finance Committee,s vote ... insurance reform bill to President Obama,s desk that will lower ... improve quality, and make health care affordable for the middle ...
... more pre-term infants survive, doctors see more babies with ... News) -- Increased survival of extremely pre-term infants has ... problems caused by abnormal development of blood vessels in ... looked at data on 506 extremely pre-term infants (born ...
... Parents today favor choices that have recently risen in popularity, ... parents like baby names that are not merely popular but ... of favor, a new study suggests. , The findings by ... that parental naming choices are influenced by trends in ways ...
... , LITTLE ROCK, Ark., Oct. 13 Keeping fit at a ... long and healthy life, according to new research co-authored by researcher ... the University of Warwick in the United Kingdom. , The ... September 30 and was based on data gathered since 1976 from ...
... 13 SRI International, an independent, nonprofit research ... been awarded a $1.55M U.S. Department of Defense/Prostate ... preclinical studies of SRI,s novel agents that have ... goal of the program is to discover treatments ...
Cached Medicine News:Health News:Eye Problems Increasing in Preemies 2Health News:Baby Names Prone to Boom-and-Bust Cycles 2Health News:For Older Adults, Good Nutrition and Exercise Are Key To Staying Healthy & Active 2Health News:For Older Adults, Good Nutrition and Exercise Are Key To Staying Healthy & Active 3Health News:SRI International Awarded a Department of Defense 'Laboratory-Clinical Transition' Grant to Advance SRI's Novel Anticancer Agents for Prostate Cancer Treatment 2Health News:SRI International Awarded a Department of Defense 'Laboratory-Clinical Transition' Grant to Advance SRI's Novel Anticancer Agents for Prostate Cancer Treatment 3
(Date:10/22/2014)... Oct. 22, 2014 InVivo Therapeutics Holdings Corp. ... is revolutionizing spinal cord injury (SCI) treatment with ... to outperform in tissue regrowth in the spinal cord ... from an FDA approved polymer, the scaffold ultimately breaks ... to the human body. NVIV has recently attracted significant ...
(Date:10/22/2014)... REDWOOD CITY, Calif. , Oct. 22, 2014 ... ) today announced that results from the  IAP310 ... and Pain Medicine (RAPM), a peer-reviewed journal ... placebo-controlled, Phase 3 trial evaluating the safety and ... sufentanil sublingual tablet system (SSTS), for the treatment ...
(Date:10/20/2014)... MOUNTAIN VIEW, California , 20 de octubre ... un líder en el campo de la pulmonología ... en su Estudio RENEW, casi 3 meses antes ... prueba fundamental de exención de dispositivo de investigación ... y Medicamentos) para el sistema de espiral de ...
Breaking Medicine Technology:InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 2InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 3AcelRx Announces Publication of Zalviso Phase 3 Abdominal Trial Results 2PneumRx concluye inscripción en prueba fundamental RENEW 2PneumRx concluye inscripción en prueba fundamental RENEW 3
... HANOVER, N.J., Dec. 3, 2010 A newly published ... first-line treatment regimen including Zometa® (zoledronic acid) significantly improved ... diagnosed multiple myeloma patients compared with a regimen that ... of the effect of Zometa on bone complications (also ...
... Ariz., Dec. 3, 2010 Sunridge International (OTC Bulletin Board: ... Richard Smith will conduct a public conference call on Monday ... call is to provide a short update on the company,s ... the public and a question and answer period will be ...
Cached Medicine Technology:Phase III Data Published in Lancet Show Novartis Drug Zometa® Improves Overall Survival in Newly Diagnosed Multiple Myeloma Patients 2Phase III Data Published in Lancet Show Novartis Drug Zometa® Improves Overall Survival in Newly Diagnosed Multiple Myeloma Patients 3Phase III Data Published in Lancet Show Novartis Drug Zometa® Improves Overall Survival in Newly Diagnosed Multiple Myeloma Patients 4Phase III Data Published in Lancet Show Novartis Drug Zometa® Improves Overall Survival in Newly Diagnosed Multiple Myeloma Patients 5Phase III Data Published in Lancet Show Novartis Drug Zometa® Improves Overall Survival in Newly Diagnosed Multiple Myeloma Patients 6Phase III Data Published in Lancet Show Novartis Drug Zometa® Improves Overall Survival in Newly Diagnosed Multiple Myeloma Patients 7Phase III Data Published in Lancet Show Novartis Drug Zometa® Improves Overall Survival in Newly Diagnosed Multiple Myeloma Patients 8
... Point-of Care Electronic Medical Record portion of ... documentation process and electronic patient record solution ... is both mobile and secure. Using a ... pentop technology with a stylus device, physicians ...
... Practice Partner Patient Records provides a ... both office and clinical efficiency, while ... Patient Records allows practices to replace ... feature set utilized nationwide by over ...
... Eyecare Advantage is one of ... Optometric practice management software is what ... ago! Compulink is among today's leaders ... Compulink's Eyecare Advantage integrates all the ...
... over 2,500 ophthalmologists nationwide, ... serve one of the ... in the country. With ... we are setting new ...
Medicine Products: